Data News > Top gainers in Biotechnology and Gene Therapy - CRSP, BIIB, REGN, VRTX, BIO
CRSP is trading UP for the last 1 days, and it at trading at $39.39 with volume of 1,493,994 and a one day change of $0.74 (1.91%). CRISPR Therapeutics AG has a 52-week low of 43.42 and a 52-week high of $91.10. The business's 50-day moving average price is $48.92 and its 200 day moving average price is $51.22. The firm has a market cap of $3 million, a P/E ratio of 14.17, and a beta of 1.66.
For more information on CRSP:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
BIIB is trading UP for the last 1 days, and it at trading at $152.87 with volume of 870,881 and a one day change of $2.68 (1.78%). Biogen Inc. has a 52-week low of 153.63 and a 52-week high of $268.30. The business's 50-day moving average price is $168.40 and its 200 day moving average price is $200.81. The firm has a market cap of $22 million, a P/E ratio of 27.69, and a beta of -0.06.
For more information on BIIB:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
REGN is trading UP for the last 1 days, and it at trading at $712.49 with volume of 329,112 and a one day change of $9.90 (1.41%). Regeneron Pharmaceuticals, Inc. has a 52-week low of 735.95 and a 52-week high of $1,211.20. The business's 50-day moving average price is $820.02 and its 200 day moving average price is $1,020.05. The firm has a market cap of $77 million, a P/E ratio of 28.73, and a beta of 0.14.
For more information on REGN:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
VRTX is trading UP for the last 1 days, and it at trading at $402.70 with volume of 751,651 and a one day change of $3.35 (0.84%). Vertex Pharmaceuticals Incorporated has a 52-week low of 351.44 and a 52-week high of $519.88. The business's 50-day moving average price is $473.54 and its 200 day moving average price is $476.32. The firm has a market cap of $102 million, a P/E ratio of 25.09, and a beta of 0.39.
Vertex Pharmaceuticals' suzetrigine showed lackluster Phase II results, but I still see potential in the non-addictive pain management market given the opioid crisis. Vertex's dominance in the cystic fibrosis (CF) drug market, including recent FDA approval for Alyftrek, ensures strong revenue and market expansion. The company's pipeline diversification, targeting diabetic peripheral neuropathy, IgA nephropathy, type 1 diabetes, and gene editing, promises long-term growth. NEW YORK, NY / ACCESSWIRE / December 31, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX) concerning possible violations of federal securities laws. On December 19, 2024, the company reported disappointing results from its RewinD-LB Phase 2b clinical trial for the pain drug suzetrigine.
For more information on VRTX:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
BIO is trading UP for the last 1 days, and it at trading at $328.77 with volume of 79,292 and a one day change of $2.43 (0.74%). Bio-Rad Laboratories, Inc. has a 52-week low of 262.12 and a 52-week high of $386.54. The business's 50-day moving average price is $342.11 and its 200 day moving average price is $319.75. The firm has a market cap of $9 million, a P/E ratio of 0.00, and a beta of 0.94.
For more information on BIO:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
Top gainers in Biotechnology and Gene Therapy - CRSP, BIIB, REGN, VRTX, BIO
By KlickAnalytics Data Insights | December 31, 2024 04:38PM ET
Following are the Top 5 companies based on their one-day percentage change within the 'Biotechnology and Gene Therapy' theme.
CRISPR Therapeutics AG (CRSP)
CRSP is trading UP for the last 1 days, and it at trading at $39.39 with volume of 1,493,994 and a one day change of $0.74 (1.91%). CRISPR Therapeutics AG has a 52-week low of 43.42 and a 52-week high of $91.10. The business's 50-day moving average price is $48.92 and its 200 day moving average price is $51.22. The firm has a market cap of $3 million, a P/E ratio of 14.17, and a beta of 1.66.
For more information on CRSP:
Biogen Inc. (BIIB)
BIIB is trading UP for the last 1 days, and it at trading at $152.87 with volume of 870,881 and a one day change of $2.68 (1.78%). Biogen Inc. has a 52-week low of 153.63 and a 52-week high of $268.30. The business's 50-day moving average price is $168.40 and its 200 day moving average price is $200.81. The firm has a market cap of $22 million, a P/E ratio of 27.69, and a beta of -0.06.
For more information on BIIB:
Regeneron Pharmaceuticals, Inc. (REGN)
REGN is trading UP for the last 1 days, and it at trading at $712.49 with volume of 329,112 and a one day change of $9.90 (1.41%). Regeneron Pharmaceuticals, Inc. has a 52-week low of 735.95 and a 52-week high of $1,211.20. The business's 50-day moving average price is $820.02 and its 200 day moving average price is $1,020.05. The firm has a market cap of $77 million, a P/E ratio of 28.73, and a beta of 0.14.
For more information on REGN:
Vertex Pharmaceuticals Incorporated (VRTX)
VRTX is trading UP for the last 1 days, and it at trading at $402.70 with volume of 751,651 and a one day change of $3.35 (0.84%). Vertex Pharmaceuticals Incorporated has a 52-week low of 351.44 and a 52-week high of $519.88. The business's 50-day moving average price is $473.54 and its 200 day moving average price is $476.32. The firm has a market cap of $102 million, a P/E ratio of 25.09, and a beta of 0.39.
Top news headlines for VRTX
For more information on VRTX:
Bio-Rad Laboratories, Inc. (BIO)
BIO is trading UP for the last 1 days, and it at trading at $328.77 with volume of 79,292 and a one day change of $2.43 (0.74%). Bio-Rad Laboratories, Inc. has a 52-week low of 262.12 and a 52-week high of $386.54. The business's 50-day moving average price is $342.11 and its 200 day moving average price is $319.75. The firm has a market cap of $9 million, a P/E ratio of 0.00, and a beta of 0.94.
For more information on BIO:
This article was generated by KlickAnalytics data insight content engine.
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.